11 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... corticosteroid; LABA ... #Algorithm #Management ... #Pulmonary #LABA ... #ICS #Pharmacology
The algorithm below shows how pre-test probability could be combined with various criteria to determine which
The algorithm below ... short course of treatment ... provide empiric treatment ... awaiting an HSV PCR ... is proposed: #Management
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Miller Fischer and PCB ... Labs: - AchR antibodies ... - Symptomatic Treatment ... precipitated by: Drugs, infection ... Gravis #diagnosis #management
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Diagnosis: • Labs ... Differential Diagnosis: Infection ... fluid overload, PCC ... APML #diagnosis #management
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
Histoplasmosis Treatment ... Diagnosis: • Labs ... Mucormycosis Treatment ... throat, skin, scalp ... Fungal #Diagnosis #Management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
is vital while lab ... #differential #algorithm ... #management #cardiology ... #treatment #table ... icu #clinical #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Skin exam for infection ... event, follow ACC algorithm ... since elective PCI ... Determine if any labs ... medical and surgical management
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
recommended for KS treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
Prevention and Treatment ... IDSA #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #management ... #pharmacology